eye treatment biosimilar
Scope
Date
~
-
Earnings
Lotte Chemical projects recovery in Q2 after 4th consecutive loss in Q1
Lotte Chemical Corp. suffered its fourth consecutive operating loss in the first quarter due to a prolonged petrochemical slowdown amid the global e...
May 11, 2023 (Gmt+09:00)
-
Business & Politics
US eyes new rules for Samsung, SK to bring chip machines to China
The US government is considering establishing new rules for South Korea’s chipmakers to import advanced equipment to China to upgrade their fa...
May 10, 2023 (Gmt+09:00)
-
Economy
Seoul eyes opening doors to domestic helpers from Southeast Asia
Seoul is slated to welcome domestic helpers from Southeast Asia later this year to ease the burden of childcare and address issues surrounding Korea...
May 08, 2023 (Gmt+09:00)
-
Korean startups
S.Korean startups eye on Southeast Asia as promising market
SINGAPORE - Southeast Asia with a youth population constituting about one-third of the region’s total population and surging internet penetrat...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Batteries
SKIET to supply battery separators to major client in China
South Korea’s battery separator maker SK IE Technology Co. (SKIET) will supply separators to a major electric vehicle (EV) battery maker in Ch...
May 02, 2023 (Gmt+09:00)
-
Sovereign wealth funds
KIC mulls expanding assets in Asian emerging markets: CEO
NEW YORK – Sovereign wealth fund Korea Investment Corporation (KIC) is considering expanding alternative investments in Asian emerging markets...
Apr 28, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
S.Korea’s HD KSOE, Samsung Heavy post surplus amid order rally
South Korea’s HD Korea Shipbuilding & Offshore Engineering (KSOE) and Samsung Heavy Industries (SHI) posted good performance in the firs...
Apr 28, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Korean startups
Asleep dreams big to help sleepless people worldwide find right treatment
Armed with artificial intelligence and big data technologies, Asleep hopes to find the best treatment for sleep-deprived people around the world wit...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Pre-IPOs
GS Group's petrochem equipment unit eyes up to $154 mn via pre-IPO
GS Entec Corp., a South Korean equipment maker for petrochemical and power plants, is set to raise 150 billion to 200 billion won ($115 million-$154...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Korean startups
ASICLAND, TSMC’s sole Korean partner, eyes 2023 IPO
ASICLAND Co. is the only South Korean semiconductor design house for the world’s largest foundry TSMC Co., which manufactures chips for about ...
Apr 12, 2023 (Gmt+09:00)
-
Korean chipmakers
DRAM prices rebound on Samsung output cut; earlier recovery eyed
Memory chip prices are staging a rebound for the first time in more than a year following Samsung Electronics Co.'s near-term production cut, b...
Apr 12, 2023 (Gmt+09:00)
-
Korean stock market
Super-rich Koreans eye return to stocks despite weaker economy
The super-rich in South Korea are eyeing stocks for investments despite a slowdown in Asia’s fourth-largest economy this year, expecting the l...
Apr 10, 2023 (Gmt+09:00)
-
Earnings
LG Electronics eyes solid Q2 results after Q1 earnings surprise
LG Electronics Inc. is expected to report solid earnings for the second quarter after its first-quarter operating profit beat market expectations an...
Apr 09, 2023 (Gmt+09:00)
-
Private equity
MBK Partners eyes China’s local consumption: Letter to investors
Private equity giant MBK Partners focused on defending its portfolio last year, especially Chinese companies during the lockdown, while being active...
Apr 03, 2023 (Gmt+09:00)
-
Shareholder activism
S.Korean activist fund KCGI eyes foundry DB HiTek buyout
Korea Corporate Governance Improvement Fund (KCGI) is eyeing a controlling stake in DB HiTek Co. as the activist fund became the second-largest shar...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Biosimilar giant Celltrion to transform into drug developer
South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's microneedle maker Raphas to enter US market
South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics se...
Mar 27, 2023 (Gmt+09:00)
-
Food & Beverage
Instant noodle maker Nongshim eyes 3rd plant in US
South Korean instant noodle giant Nongshim Co. is looking to build its third manufacturing plant in the US as the company is seeing sales of its pro...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q
NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
PharmaResearch pays employees $7,706 bonus for having 3rd child
With South Korea setting new lows in birth rate every year, PharmaResearch on Wednesday said it will adopt an unprecedented system of childbirth and...
Mar 23, 2023 (Gmt+09:00)
-
Batteries
EcoPro taps mines in the Americas to secure cathode materials: EcoPro CEO
EcoPro Group, South Korea’s leading battery materials producer, is mulling investments in mines in the Americas to source cathode materials, a...
Mar 22, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion eyes Baxter's arm as it gears up for M&As
Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...
Mar 21, 2023 (Gmt+09:00)
-
Waste management
Toray Advanced Materials acquires S.Korea's water treatment company
Toray Advanced Materials Korea Inc. announced on Monday the acquisition of Hanmee Entec Co., Ltd., the industry's longest-running water treatment fa...
Mar 20, 2023 (Gmt+09:00)
-
Regulations
Korea to ease foreign ownership limit rules; MSCI upgrade eyed
South Korea plans to ease regulations that limit foreign ownership of big companies deemed crucial to its economy as the government aims to align it...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)